Charles-Antoine Guelluy is a partner in Latham & Watkins' Paris office. He has extensive experience representing clients in mergers and acquisitions, private equity, and stock exchange regulations, and is actively engaged in all aspects of real estate law, focusing on the sale and purchase of real estate companies and portfolios.

Recognition Highlights

Recognized as a key contact for Leveraged Buy-Outs.
The Legal 500 EMEA 2021

Recognized as a Notable Practitioner.
IFLR 1000 France 2020

Recognized among leading practitioners in Private Equity.
The Legal 500 EMEA 2020

Mr. Guelluy's experience includes advising:

  • PSP Investments on Fives Group’s share capital increase
  • Inari Medical in its acquisition of LimFlow
  • Nissan Motor Co., Ltd on its entrance into definitive agreements with Renault Group
  • Imerys, the world leader in mineral-based specialty solutions for industry, in its exclusive negotiations to sell its High Temperature Solutions business (HTS) to Platinum Equity
  • Fortress Investment Group in the restructuring of Football Club des Girondins de Bordeaux (Bordeaux FC)
  • Farallon Capital as subscriber of GreenYellow’s issue of €109 million convertible bonds with warrants attached; GreenYellow is a leading energy transition company and subsidiary of Casino Group
  • Certares in the context of the backing process of the Pierre & Vacances – Center Parcs group 
  • Bloom & Wild in its acquisition of Bergamotte, Europe’s leading online flower company
  • Fortress Investment Group on the sale and refinancing of Bordeaux FC, a French professional football team
  • Veracyte in its acquisition of HalioDx, a French immuno-oncology diagnostics company
  • Public Sector Pension Investment Board in its acquisition with La Caisse de Dépôt et Placement du Québec of undisclosed minority stake in Fives, a France-based industrial engineering company
  • Groupe Bertrand in connection with Burger King France and quick refinancing of existing indebtedness
  • Air Liquide in its investment in CellNovo, a France and UK-based company that has developed the first connected all in one diabetes management system
  • Andromède in the context of an equity investment in Alboran
  • Andromède in its acquisition of Verquin Reims Cathédrale, a France-based hotel located in Reims
  • Intermediate Capital Group and Sagesse Retraite Santé in their acquisition of a majority stake in DomusVi, a France-based provider of services to elderly people including nursing homes, residential facilities, and home care
  • MédiPôle Partenaires SAS, a France-based owner and operator of private hospitals and health care facilities, in the minority investment of BPI France into the group
  • Sodalis S.r.l. in its acquisition of Inventia, a France-based manufacturer and distributor of hygiene and beauty products
  • Ardian in relation with the acquisition of the biologist group, Bio 7, from Chequers Capital

Bar Qualification

  • Avocat (Paris)


  • Graduate Degree Business Law, University of Paris II (Panthéon-Assas), 1993
  • Postgraduate Degree Public Affairs, Institut d’Études Politiques de Paris, 1992
  • MBA, ESSEC Graduate School of Management, 1990